139 related articles for article (PubMed ID: 1586592)
1. Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.
Bartlett JM; Rabiasz GJ; Scott WN; Langdon SP; Smyth JF; Miller WR
Br J Cancer; 1992 May; 65(5):655-60. PubMed ID: 1586592
[TBL] [Abstract][Full Text] [Related]
2. Endothelin expression and responsiveness in human ovarian carcinoma cell lines.
Moraitis S; Langdon SP; Miller WR
Eur J Cancer; 1997 Apr; 33(4):661-8. PubMed ID: 9274451
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
[TBL] [Abstract][Full Text] [Related]
4. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
[TBL] [Abstract][Full Text] [Related]
5. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
6. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines.
Crew AJ; Langdon SP; Miller EP; Miller WR
Eur J Cancer; 1992; 28(2-3):337-41. PubMed ID: 1591048
[TBL] [Abstract][Full Text] [Related]
8. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
Zeinoun Z; Teugels E; De Bleser PJ; Neyns B; Geerts A; De Greve J
Anticancer Res; 1999; 19(1A):413-20. PubMed ID: 10226576
[TBL] [Abstract][Full Text] [Related]
9. Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors.
Bartlett JM; Rabiasz GJ; Scott WN; Langdon SP; Hirst GL; Lee A; Smyth JF; Miller WR
Oncol Rep; 1995 Sep; 2(5):857-62. PubMed ID: 21597831
[TBL] [Abstract][Full Text] [Related]
10. Growth regulation of ovarian cancer cell line HO-8910 by transforming growth factor beta 1 in vitro.
Chen X; Zheng S; Gao Y; Dai H; Mou H; Yang H
Chin Med J (Engl); 1998 Jun; 111(6):546-50. PubMed ID: 11245077
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor-beta 1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: implications for endometriosis and peritoneal adhesion formation.
Dou Q; Williams RS; Chegini N
Mol Hum Reprod; 1997 May; 3(5):383-91. PubMed ID: 9239722
[TBL] [Abstract][Full Text] [Related]
12. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.
Havrilesky LJ; Hurteau JA; Whitaker RS; Elbendary A; Wu S; Rodriguez GC; Bast RC; Berchuck A
Cancer Res; 1995 Feb; 55(4):944-8. PubMed ID: 7531618
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
14. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma.
Jindal SK; Ishii E; Letarte M; Vera S; Teerds KJ; Dorrington JH
Biol Reprod; 1995 May; 52(5):1027-37. PubMed ID: 7626702
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
[TBL] [Abstract][Full Text] [Related]
16. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.
Higashi T; Sasagawa T; Inoue M; Oka R; Shuangying L; Saijoh K
Jpn J Cancer Res; 2001 May; 92(5):506-15. PubMed ID: 11376559
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
Khosla S; Oursler MJ; Schroeder MJ; Eberhardt NL
Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
[TBL] [Abstract][Full Text] [Related]
20. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
